Invention Grant
- Patent Title: Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication
-
Application No.: US15115758Application Date: 2015-02-10
-
Publication No.: US09932356B2Publication Date: 2018-04-03
- Inventor: John F. Kadow , David R. Langley , B. Narasimhulu Naidu , Kevin Peese , Zhongyu Wang
- Applicant: VIIV HEALTHCARE UK (No. 5) LIMITED
- Applicant Address: GB Brentford, Middlesex
- Assignee: ViiV HEALTHCARE UK (NO. 5) LIMITED
- Current Assignee: ViiV HEALTHCARE UK (NO. 5) LIMITED
- Current Assignee Address: GB Brentford, Middlesex
- Agent Robert H. Brink; Edward R. Gimmi; William R. Majarian
- International Application: PCT/US2015/015154 WO 20150210
- International Announcement: WO2015/123182 WO 20150820
- Main IPC: C07D513/22
- IPC: C07D513/22 ; C07D498/22 ; C07D471/22
Abstract:
The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection.
Public/Granted literature
- US20170015683A1 PYRAZOLOPYRIMIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION Public/Granted day:2017-01-19
Information query
